<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2023, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 13 Jul 2023 10:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>IQ-AI Announces Orphan Drug Designation for GaM in Pediatric GBM</title>
   <link>http://www.streetinsider.com/Press+Releases/IQ-AI+Announces+Orphan+Drug+Designation+for+GaM+in+Pediatric+GBM/21905206.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/IQ-AI+Announces+Orphan+Drug+Designation+for+GaM+in+Pediatric+GBM/21905206.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/IQ-AI+Announces+Orphan+Drug+Designation+for+GaM+in+Pediatric+GBM/21905206.html</guid>
   <pubDate>Thu, 13 Jul 2023 10:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>IQ-AI Announces Orphan Drug Designation for GaM in Pediatric GBM</title>
   <link>http://www.streetinsider.com/Accesswire/IQ-AI+Announces+Orphan+Drug+Designation+for+GaM+in+Pediatric+GBM/21905206.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/IQ-AI+Announces+Orphan+Drug+Designation+for+GaM+in+Pediatric+GBM/21905206.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Accesswire/IQ-AI+Announces+Orphan+Drug+Designation+for+GaM+in+Pediatric+GBM/21905206.html</guid>
   <pubDate>Thu, 13 Jul 2023 10:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>IQ-AI Announces Orphan Drug Designation Status</title>
   <link>http://www.streetinsider.com/Press+Releases/IQ-AI+Announces+Orphan+Drug+Designation+Status/21295565.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/IQ-AI+Announces+Orphan+Drug+Designation+Status/21295565.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/IQ-AI+Announces+Orphan+Drug+Designation+Status/21295565.html</guid>
   <pubDate>Tue, 28 Feb 2023 13:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>IQ-AI Announces Orphan Drug Designation Status</title>
   <link>http://www.streetinsider.com/Accesswire/IQ-AI+Announces+Orphan+Drug+Designation+Status/21295565.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/IQ-AI+Announces+Orphan+Drug+Designation+Status/21295565.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Accesswire/IQ-AI+Announces+Orphan+Drug+Designation+Status/21295565.html</guid>
   <pubDate>Tue, 28 Feb 2023 13:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>Planet MicroCap Review Magazine for Q3 2022 Now Online</title>
   <link>http://www.streetinsider.com/Press+Releases/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</guid>
   <pubDate>Wed, 19 Oct 2022 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CXDO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MMMB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RELI</category>
   	  </item>
  <item>
   <title>Planet MicroCap Review Magazine for Q3 2022 Now Online</title>
   <link>http://www.streetinsider.com/Accesswire/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Accesswire/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</guid>
   <pubDate>Wed, 19 Oct 2022 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CXDO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MMMB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RELI</category>
   	  </item>
  <item>
   <title>Planet MicroCap Review Magazine for Q3 2022 Now Online</title>
   <link>http://www.streetinsider.com/Press+Releases/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</guid>
   <pubDate>Wed, 19 Oct 2022 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CXDO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MMMB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RELI</category>
   	  </item>
  <item>
   <title>Planet MicroCap Review Magazine for Q3 2022 Now Online</title>
   <link>http://www.streetinsider.com/Accesswire/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Accesswire/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</guid>
   <pubDate>Wed, 19 Oct 2022 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CXDO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MMMB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RELI</category>
   	  </item>
  <item>
   <title>Planet MicroCap Review Magazine for Q3 2022 Now Online</title>
   <link>http://www.streetinsider.com/Press+Releases/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</guid>
   <pubDate>Wed, 19 Oct 2022 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CXDO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MMMB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RELI</category>
   	  </item>
  <item>
   <title>Planet MicroCap Review Magazine for Q3 2022 Now Online</title>
   <link>http://www.streetinsider.com/Accesswire/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Accesswire/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</guid>
   <pubDate>Wed, 19 Oct 2022 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CXDO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MMMB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RELI</category>
   	  </item>
  <item>
   <title>Planet MicroCap Review Magazine for Q3 2022 Now Online</title>
   <link>http://www.streetinsider.com/Press+Releases/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</guid>
   <pubDate>Wed, 19 Oct 2022 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CXDO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MMMB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RELI</category>
   	  </item>
  <item>
   <title>Planet MicroCap Review Magazine for Q3 2022 Now Online</title>
   <link>http://www.streetinsider.com/Accesswire/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Accesswire/Planet+MicroCap+Review+Magazine+for+Q3+2022+Now+Online/20719384.html</guid>
   <pubDate>Wed, 19 Oct 2022 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CXDO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MMMB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RELI</category>
   	  </item>
  <item>
   <title>Imaging Biometrics Submits FDA 510(k) Application for IB Zero G</title>
   <link>http://www.streetinsider.com/Press+Releases/Imaging+Biometrics+Submits+FDA+510%28k%29+Application+for+IB+Zero+G/20151783.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Imaging+Biometrics+Submits+FDA+510%28k%29+Application+for+IB+Zero+G/20151783.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Imaging+Biometrics+Submits+FDA+510%28k%29+Application+for+IB+Zero+G/20151783.html</guid>
   <pubDate>Tue, 31 May 2022 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>Imaging Biometrics Submits FDA 510(k) Application for IB Zero G</title>
   <link>http://www.streetinsider.com/Accesswire/Imaging+Biometrics+Submits+FDA+510%28k%29+Application+for+IB+Zero+G/20151783.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Imaging+Biometrics+Submits+FDA+510%28k%29+Application+for+IB+Zero+G/20151783.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Accesswire/Imaging+Biometrics+Submits+FDA+510%28k%29+Application+for+IB+Zero+G/20151783.html</guid>
   <pubDate>Tue, 31 May 2022 09:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>IB Neuro's Quantitative Mapping Method Assesses Metastatic Tumors</title>
   <link>http://www.streetinsider.com/Press+Releases/IB+Neuro%27s+Quantitative+Mapping+Method+Assesses+Metastatic+Tumors/20007100.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/IB+Neuro%27s+Quantitative+Mapping+Method+Assesses+Metastatic+Tumors/20007100.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/IB+Neuro%27s+Quantitative+Mapping+Method+Assesses+Metastatic+Tumors/20007100.html</guid>
   <pubDate>Tue, 03 May 2022 10:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>IB Neuro's Quantitative Mapping Method Assesses Metastatic Tumors</title>
   <link>http://www.streetinsider.com/Accesswire/IB+Neuro%27s+Quantitative+Mapping+Method+Assesses+Metastatic+Tumors/20007100.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/IB+Neuro%27s+Quantitative+Mapping+Method+Assesses+Metastatic+Tumors/20007100.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Accesswire/IB+Neuro%27s+Quantitative+Mapping+Method+Assesses+Metastatic+Tumors/20007100.html</guid>
   <pubDate>Tue, 03 May 2022 10:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>Innovative Therapy that &amp;quot;Tricks&amp;quot; and Destroys Cancer Cells Advances to Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</guid>
   <pubDate>Fri, 08 Apr 2022 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19354901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>Innovative Therapy that &amp;quot;Tricks&amp;quot; and Destroys Cancer Cells Advances to Clinical Trial</title>
   <link>http://www.streetinsider.com/PRNewswire/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</guid>
   <pubDate>Fri, 08 Apr 2022 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19354901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>Innovative Therapy that &amp;quot;Tricks&amp;quot; and Destroys Cancer Cells Advances to Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</guid>
   <pubDate>Fri, 08 Apr 2022 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19354901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>Innovative Therapy that &amp;quot;Tricks&amp;quot; and Destroys Cancer Cells Advances to Clinical Trial</title>
   <link>http://www.streetinsider.com/PRNewswire/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</guid>
   <pubDate>Fri, 08 Apr 2022 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19354901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>Innovative Therapy that &amp;quot;Tricks&amp;quot; and Destroys Cancer Cells Advances to Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</guid>
   <pubDate>Fri, 08 Apr 2022 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19354901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>Innovative Therapy that &amp;quot;Tricks&amp;quot; and Destroys Cancer Cells Advances to Clinical Trial</title>
   <link>http://www.streetinsider.com/PRNewswire/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</guid>
   <pubDate>Fri, 08 Apr 2022 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19354901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>Innovative Therapy that &amp;quot;Tricks&amp;quot; and Destroys Cancer Cells Advances to Clinical Trial</title>
   <link>http://www.streetinsider.com/Press+Releases/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</guid>
   <pubDate>Fri, 08 Apr 2022 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19354901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>Innovative Therapy that &amp;quot;Tricks&amp;quot; and Destroys Cancer Cells Advances to Clinical Trial</title>
   <link>http://www.streetinsider.com/PRNewswire/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Innovative+Therapy+that+%26quot%3BTricks%26quot%3B+and+Destroys+Cancer+Cells+Advances+to+Clinical+Trial/19893456.html</guid>
   <pubDate>Fri, 08 Apr 2022 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19354901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19655944</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
  <item>
   <title>IQAI's Sponsored Phase I Clinical Trial is Open</title>
   <link>http://www.streetinsider.com/Press+Releases/IQAI%27s+Sponsored+Phase+I+Clinical+Trial+is+Open/19757531.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/IQAI%27s+Sponsored+Phase+I+Clinical+Trial+is+Open/19757531.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/IQAI%27s+Sponsored+Phase+I+Clinical+Trial+is+Open/19757531.html</guid>
   <pubDate>Thu, 10 Mar 2022 11:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IQAIF</category>
   	  </item>
 </channel>
</rss>
